| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Vesicle amine transport protein 1 homolog (T. californica)-like (VAT1L) from ORIGENE TECHNOLOGIES | LY412225 | 100 ug | ORIGENE TECHNOLOGIES |
| Vesicle amine transport protein 1 homolog (T. californica) (VAT1) from ORIGENE TECHNOLOGIES | LY401915 | 100 ug | ORIGENE TECHNOLOGIES |
| Vesicle-associated membrane protein 3 (cellubrevin) (VAMP3) from ORIGENE TECHNOLOGIES | LY401501 | 100 ug | ORIGENE TECHNOLOGIES |
| Vesicle-associated membrane protein 8 (endobrevin) (VAMP8) from ORIGENE TECHNOLOGIES | LY401238 | 100 ug | ORIGENE TECHNOLOGIES |
| Vesicle-associated membrane protein 5 (myobrevin) (VAMP5) from ORIGENE TECHNOLOGIES | LY416522 | 100 ug | ORIGENE TECHNOLOGIES |
| Vesicle-associated membrane protein 2 (synaptobrevin 2) (VAMP2) from ORIGENE TECHNOLOGIES | LY415423 | 100 ug | ORIGENE TECHNOLOGIES |
| Vesicle-associated membrane protein 1 (synaptobrevin 1) (VAMP1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415422 | 100 ug | ORIGENE TECHNOLOGIES |
| Vesicle-associated membrane protein 1 (synaptobrevin 1) (VAMP1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429412 | 100 ug | ORIGENE TECHNOLOGIES |
| Vesicle-associated membrane protein 1 (synaptobrevin 1) (VAMP1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY413817 | 100 ug | ORIGENE TECHNOLOGIES |
| Vesicle-associated membrane protein 1 (synaptobrevin 1) (VAMP1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404313 | 100 ug | ORIGENE TECHNOLOGIES |
| Vesicle-associated membrane protein 4 (VAMP4) from ORIGENE TECHNOLOGIES | LY418448 | 100 ug | ORIGENE TECHNOLOGIES |
| Vesicle-associated membrane protein 4 (VAMP4), transcript variant 2 from ORIGENE TECHNOLOGIES | LY433976 | 100 ug | ORIGENE TECHNOLOGIES |
| Vesicle transport through interaction with t-SNAREs homolog 1A (yeast) (VTI1A) from ORIGENE TECHNOLOGIES | LY407945 | 100 ug | ORIGENE TECHNOLOGIES |
| Vesicle transport through interaction with t-SNAREs homolog 1B (yeast) (VTI1B) from ORIGENE TECHNOLOGIES | LY416689 | 100 ug | ORIGENE TECHNOLOGIES |
| Vesicular, overexpressed in cancer, prosurvival protein 1 (VOPP1) from ORIGENE TECHNOLOGIES | LY403081 | 100 ug | ORIGENE TECHNOLOGIES |
| Vestigial like 1 (Drosophila) (VGLL1) from ORIGENE TECHNOLOGIES | LY414087 | 100 ug | ORIGENE TECHNOLOGIES |
| Vestigial like 2 (Drosophila) (VGLL2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY405429 | 100 ug | ORIGENE TECHNOLOGIES |
| Vestigial like 2 (Drosophila) (VGLL2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY407038 | 100 ug | ORIGENE TECHNOLOGIES |
| Vestigial like 4 (Drosophila) (VGLL4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426931 | 100 ug | ORIGENE TECHNOLOGIES |
| Vestigial like 4 (Drosophila) (VGLL4), transcript variant 2 from ORIGENE TECHNOLOGIES | LY415121 | 100 ug | ORIGENE TECHNOLOGIES |
| Vestigial like 4 (Drosophila) (VGLL4), transcript variant 4 from ORIGENE TECHNOLOGIES | LY426933 | 100 ug | ORIGENE TECHNOLOGIES |
| V-ets erythroblastosis virus E26 oncogene homolog (avian) (ERG), transcript variant 1 from ORIGENE TECHNOLOGIES | LY403650 | 100 ug | ORIGENE TECHNOLOGIES |
| Vestigial like 3 (Drosophila) (VGLL3) from ORIGENE TECHNOLOGIES | LY414120 | 100 ug | ORIGENE TECHNOLOGIES |
| V-ets erythroblastosis virus E26 oncogene homolog (avian) (ERG), transcript variant 2 from ORIGENE TECHNOLOGIES | LY401413 | 100 ug | ORIGENE TECHNOLOGIES |
| V-ets erythroblastosis virus E26 oncogene homolog (avian) (ERG), transcript variant 3 from ORIGENE TECHNOLOGIES | LY427827 | 100 ug | ORIGENE TECHNOLOGIES |
| V-ets erythroblastosis virus E26 oncogene homolog 1 (avian) (ETS1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY428365 | 100 ug | ORIGENE TECHNOLOGIES |
| V-ets erythroblastosis virus E26 oncogene homolog 1 (avian) (ETS1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY401606 | 100 ug | ORIGENE TECHNOLOGIES |
| V-ets erythroblastosis virus E26 oncogene homolog 2 (avian) (ETS2) from ORIGENE TECHNOLOGIES | LY401607 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS516441 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS524464 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS609763 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS621203 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS543299 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS622186 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS634467 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS700790 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS700791 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS700792 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS700793 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS701978 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS707874 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS707880 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS800650 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS800651 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS804679 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS804680 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS804684 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS502647 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS525651 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous, metastatic from ORIGENE TECHNOLOGIES | CS601652 | 5x5um | ORIGENE TECHNOLOGIES |